Rapid antigen assays could prove key to addressing SARS-CoV-2 testing limitations
Skip to main content
MDHC_Logotype_white
Subscribe
  • My Account
  • Login
  • Subscribe
  • News
    • This Week's News
    • COVID-19
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • People
    • Regional News
    • Digital Edition
    • Rural residents twice as likely to leave Medicare Advantage as urbanites, study says
      Bundled payments reduce surgery costs by 10.7%, study finds
      Average nursing home nursing staff turnover exceeds 100%, report finds
      Highmark, HealthNow finalize affiliation, creating fourth-largest Blues plan
    • Average nursing home nursing staff turnover exceeds 100%, report finds
      Utah cancels vaccine appointments after registration error
      The Check Up: Dr. Marc Boom
      The Check Up: Dr. Marc Boom of Houston Methodist
      Dr. Marc Boom
      Q&A: Houston Methodist CEO praises staff efforts to keep vaccine efforts going during ice storm
    • The Check Up: Dr. Marc Boom
      The Check Up: Dr. Marc Boom of Houston Methodist
      Dr. Marc Boom
      Q&A: Houston Methodist CEO praises staff efforts to keep vaccine efforts going during ice storm
      Charles-Shor_160x200 1_i.jpg
      Cleveland Clinic receives $15.5 million donation for new neurological institute
      Dr. Imran Andrabi
      Q&A: ThedaCare CEO says lessons from COVID-19 will inform new approaches to population health management
    • Highmark, HealthNow finalize affiliation, creating fourth-largest Blues plan
      Low 2020 utilization could affect insurer profits for the next two years, analysts say
      CMS: Group health plans must cover COVID-19 diagnostic testing
      High MLRs inspire insurers to focus on quality improvements
    • Average nursing home nursing staff turnover exceeds 100%, report finds
      CMS: Group health plans must cover COVID-19 diagnostic testing
      Another Pennsylvania health network vaccinates employee kin
      Why AstraZeneca and J&J's vaccines, in use elsewhere, are still on hold in America
    • UPMC's patient volumes stabilize, boosting 2020 profits
      Genomics firms taking advantage of SPACs trend to go public faster
      COVID-19 could dent hospital revenue by at least $53 billion in 2021, AHA says
      deloitte GDP image chart graph going up
      Sponsored Content Provided By Deloitte
      Breaking the cost curve
    • Teladoc reports $383.3M in fourth-quarter revenue, up 145%
      man and woman looking at ipad wearing face masks stock image
      Sponsored Content Provided By Surescripts
      Improvements to benefits data can enhance ePrescribing and the patient experience
      Oscar Health's $1B IPO sets the stage for more health tech exits in 2021
      A map of the U.S. with images of the coronavirus.
      The digital divide becomes a new social determinant of health
    • Utah cancels vaccine appointments after registration error
      Connecticut is doling out vaccines based strictly on age. It's simpler, but is it fair?
      Great-granddaughter of Tuskegee study victim gets vaccine
      Some GOP state lawmakers help spread COVID-19 misinformation
    • Alicia Wilson
      Q&A: Emerging leader Alicia Wilson on staying close to home
      Michael Jordan, Novant team up to address health equity
      Former Ascension CEO, the first to lead the health system, passes away
      Biden's pick to head CMS would be first Black woman to hold post
    • Midwest
    • Northeast
    • South
    • West
  • Insights
    • ACA 10 Years After
    • Best Practices
    • Special Reports
    • Innovations
    • The Affordable Care Act after 10 years
    • Dr. John Fischer
      Patient-reported outcomes tool for hernia surgery helps physicians improve care
      New care model helps primary-care practices treat obesity
      doctor with patient
      COVID-19 treatment protocol developed in the field helps patients recover
      Rachel Wyatt
      Project to curb pressure injuries in hospitals shows promise
    • What's next for on-demand telehealth companies?
      A CalOptima PACE vaccination clinic.
      Will COVID-19 be the catalyst for creating a more sustainable healthcare system?
      A map of the U.S. with images of the coronavirus.
      The digital divide becomes a new social determinant of health
      Ascension’s St. Mary’s Hospital Surgery Center at Towne Centre and Allegheny Health Network’s Bethel Park surgery center
      Hospitals see opportunity, risk in ambulatory surgery centers
    • Dr. Daniel Hall
      UPMC pilots machine learning, telehealth to inform patient transfers
      A woman being recorded using her inhaler on a smartphone.
      Digital check-ins, connected inhalers help control asthma
      A phone screen showing the question, "Mary we hope this information was helpful and we'd like to keep guiding you. Are you interested in knowing when it's your turn to receive the vaccine?"
      Chatbots, texting campaigns help manage influx of COVID vax questions
      A woman with a wearable sensor talking to her provider.
      Wearable sensors help diagnose heart rhythm problems in West Virginia
  • Transformation
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • What's next for on-demand telehealth companies?
      Rising prescription copays drop adherence, spike mortality, research shows
      Dr. John Fischer
      Patient-reported outcomes tool for hernia surgery helps physicians improve care
      Highmark Health inks six-year cloud, tech deal with Google
    • Hospitals' Medicare billing practices suggest upcoding, OIG says
      California hospitals prepare ethical protocol to prioritize lifesaving care
      Amazon, JPMorgan Chase, Berkshire Hathaway disband Haven
      Digital pathways poised to reshape healthcare continuum in 2021
    • Dr. Daniel Hall
      UPMC pilots machine learning, telehealth to inform patient transfers
      A woman being recorded using her inhaler on a smartphone.
      Digital check-ins, connected inhalers help control asthma
      Humana partners with in-home provider for 24/7 care
      A phone screen showing the question, "Mary we hope this information was helpful and we'd like to keep guiding you. Are you interested in knowing when it's your turn to receive the vaccine?"
      Chatbots, texting campaigns help manage influx of COVID vax questions
    • Bundled payments reduce surgery costs by 10.7%, study finds
      Coordinated payment policies could speed transition to value, experts say
      CMMI's geographic direct contracting model needs an overhaul, experts say
      Hospitals fight UnitedHealthcare policies over lab test, specialty drug payments
  • Data/Lists
    • Rankings/Lists
    • Interactive Databases
    • Data Points
    • Health Systems Financials
      Executive Compensation
      Physician Compensation
  • Op-Ed
    • Bold Moves
    • Breaking Bias
    • Commentaries
    • Letters
    • Vital Signs Blog
    • From the Editor
    • Dr. Alan Kaplan
      The risks, rewards of taking organizations 'where they haven’t gone before'
      Wellstar CEO calls adapting for the pandemic her bold move
      Howard P. Kern
      Recognizing the value of telehealth in its infancy
      Dr. Stephen Markovich
      A bold move helped take him from family doctor to OhioHealth CEO
    • Dr. Stephen Markovich
      Making sure we're aligned along the path to achieving inclusion
      Barry Ostrowsky
      Ending racism is a journey taken together; the starting point must be now
      Laura Lee Hall and Gary Puckrein
      Increased flu vaccination has never been more important for communities of color
      John Daniels Jr.
      Health equity: Making the journey from buzzword to reality
    • Mikelle Moore
      The promising future of rural healthcare, even amid the COVID-19 pandemic
      In-person visitation must be part of the national COVID-19 response
      We've lost so much to the pandemic, but we've also made gains that will endure
      Medical groups key to meeting president's vaccine pledge
    • Letters: Eliminating bias in healthcare needs to be ‘deliberate and organic’
      Letters: Maybe dropping out of ACOs is a good thing for patients
      Letters: White House and Congress share blame for lack of national COVID strategy
      Letters: VA making strides to improve state veterans home inspections
    • Sponsored Content Provided By Optum
      How blockchain could ease frustration with the payment process
      Sponsored Content Provided By Optum
      Three steps to better data-sharing for payer and provider CIOs
      Sponsored Content Provided By Optum
      Reduce total cost of care: 6 reasons why providers and payers should tackle the challenge together
      Sponsored Content Provided By Optum
      Why CIOs went from back-office operators to mission-critical innovators
  • Awards
    • Award Programs
    • Nominate
    • Previous Award Programs
    • Other Award Programs
    • Best Places to Work in Healthcare Logo for Navigation
      Nominations Open - Best Places to Work in Healthcare
      Nominations Open - 50 Most Influential Clinical Executives
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • Best Places to Work in Healthcare
    • Health Care Hall of Fame
    • Healthcare Marketing Impact Awards
    • Top 25 Emerging Leaders
    • Top 25 Innovators
    • Minorities in Healthcare
      • - Luminaries
      • - Top 25 Minority Leaders
      • - Minorities to Watch
    • Women in Healthcare
      • - Luminaries
      • - Top 25 Women Leaders
      • - Women to Watch
    • Excellence in Nursing Awards
    • Design Awards
    • Top 25 COOs in Healthcare
    • 100 Top Hospitals
    • ACHE Awards
  • Events
    • Conferences
    • Galas
    • Webinars
    • COVID-19 Event Tracker
    • podium march webinar logo lockup
      Sponsored Content Provided By Podium
      Webinar: Critical Touchpoints for Every Patient’s Journey — How Technology Plays an Important Role
      scp health logo lockup march 2021
      Sponsored Content Provided By SCP Health
      Webinar: COVID’s call to action — Reset for success in 2021
    • Women Leaders in Healthcare Conference
    • Social Determinants of Health Symposium
    • Healthcare Transformation Summit
    • Leadership Symposium
    • Virtual Briefings
      • - Hospital of the Future
      • - Mental Health
      • - Patient Safety & Quality
      • - Strategic Marketing
      • - Virtual Health
      • - Workplace of the Future
    • Best Places to Work Awards Gala
    • Health Care Hall of Fame Gala
    • Top 25 Minority Leaders Gala
    • Top 25 Women Leaders Gala
  • Listen
    • Podcast - Next Up
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Video Series - The Check Up
    • Sponsored Video Series - One on One
    • Next Up Podcast: Educating patients on the COVID-19 vaccine with Tanya Andreadis
      Dr. Joseph Cacchione
      Next Up Podcast: Educating patients on the COVID-19 vaccine with Dr. Joseph Cacchione
      Dr. Karen DeSalvo
      Next Up Podcast: What to expect with telehealth and healthcare technology in the next four years
      Carter Dredge
      Next Up Podcast: Ready, set, innovate! Innovation and disruption in healthcare
    • Beyond the Byline: Insurers are betting on virtual-first plans as COVID-19 shifts care pathways
      Beyond the Byline: How residents' stories shape our coverage of the vaccination rollout in nursing homes
      Beyond the Byline: Regulators aim to boost value push with fraud and abuse law updates
      An older man wearing a mask receiving a vaccine.
      Beyond the Byline: Verifying information on the chaotic COVID-19 vaccine rollout
    • Outreach during COVID-19
      Leading intention promote diversity and inclusion
      Introducing Healthcare Insider Podcast
    • The Check Up: Dr. Marc Boom
      The Check Up: Dr. Marc Boom of Houston Methodist
      The Check Up: Dr. Imran Andrabi
      The Check Up: Dr. Imran Andrabi of ThedaCare
      The Check Up: Tanya Blackmon
      The Check Up: Tanya Blackmon of Novant Health
      The Check Up: Dr. Patrick Hwu
      The Check Up: Dr. Patrick Hwu of the Moffitt Cancer Center
    • ivana naeymi-rad one on one intelligent medical objects
      Video: Ivana Naeymi Rad of Intelligent Medical Objects
  • MORE +
    • Advertise
    • Media Kit
    • Newsletters
    • Jobs
    • People on the Move
    • Reprints & Licensing
MENU
Breadcrumb
  1. Home
  2. Technology
May 08, 2020 12:13 PM

Rapid antigen assays could prove key to addressing SARS-CoV-2 testing limitations

Adam Bonislawski, 360Dx
  • Tweet
  • Share
  • Share
  • Email
  • More
    Print

    As clinicians and scientists have worked to understand and control the spread and scope of the COVID-19 pandemic, molecular testing and serology have emerged as important tools for diagnosing and studying the disease.

    Protein-based antigen testing has received relatively less attention, but their rapid turnaround time, ease of use, and amenability to large scale production, could prove valuable for addressing the outbreak.

    While serology tests measure the host's immune response to a virus, protein antigen tests are conceptually similar to molecular tests, with the former using antibodies to detect the presence of viral proteins in patient samples and the later using PCR to detect viral nucleic acid.

    Molecular tests have the advantage of amplification provided by PCR, while protein antigen tests are limited by the sensitivity of the antibodies used. This means molecular tests may be more sensitive and able to diagnose infection earlier in the process than protein tests. On the other hand, protein tests are typically easier to produce at scale and in point-of-care or home use formats. For instance, Bethlehem, Pennsylvania-based diagnostics firm OraSure Technologies, which is developing a SARS-CoV-2 antigen test, sells at-home antigen tests for HIV over-the-counter purchase in national pharmacies like Walgreens and CVS.

    And while some rapid antigen viral tests have had a reputation for poor performance, the field has made significant strides in recent years, said Nathan Ledeboer, medical director of the microbiology laboratory at the Medical College of Wisconsin and Froedtert Hospital, noting that in particular, use of better antibodies and a move from manual test reading to instrument-based reading have led to substantial improvements in test sensitivity.

    While no antigen tests for SARS-CoV-2 have come to market in the U.S. yet, a number of companies have assays in development. Several are supported by funding from the Biomedical Advanced Research and Development Authority (BARDA), which provided OraSure with $710,310 to support development of its test, as well as $638,000 to Gaithersburg, Maryland-based Hememics Biotechnologies and $569,627 to Emeryville, California-based Nanomix.

    Diagnostics firms Quidel, Roche, and Becton Dickinson have also announced they are developing SARS-CoV-2 antigen tests.

    OraSure President and CEO Stephen Tang said the company began considering developing a test as COVID-19 began spreading in January and February.

    The company plans to develop a SARS-CoV-2 that, like its HIV test, will be suitable for home use and can provide results in under an hour, Tang said. He said the company aims to launch the product in September. Tang said that OraSure can currently manufacture about 13 million tests per year.

    He noted, however, that some official plans to safely reopen the economy call for a billion tests per year.

    "We're going to have to find a way to massively scale up," he said. "We're looking to design massive manufacturing of this from the start. Our job is to find facilities and manufacturers and partners who can jump in quickly to that manufacturing environment."

    He said he anticipated being able to reach "full-scale manufacturing sometime in 2021," with a target of "tens of millions to a billion units per year."

    Nanomix CEO David Ludvigson said his company anticipated submitting its antigen test to FDA for emergency use authortization in around six weeks. The test will use nasal swabs for sample collection. Ludvigson said Nanomix aimed to get production up to around 500,000 tests per month by Q4 of this year.

    The movement of large in vitro diagnostic players like Roche, BD, and Quidel into the space could also provide significant antigen test capacity.

    On Quidel's Q1 earnings call on Wednesday, President and CEO Doug Bryant said that the company was in the final stages of development of a SARS-CoV-2 antigen test that will run on its point-of-care Sofia immunoassay system. He said Quidel plans in the near future to ship around 40,000 tests that it will use in studies to determine the performance of the test.

    In terms of capacity, Bryant said Quidel could currently produce 84 million tests a year for all of its Sofia assays as well as another 30 million QuickVeu lateral flow immunoassays. He said that the company is adding a new manufacturing line that would boost Sofia test production capacity by 30 million tests and aims ultimately to ramp to a total of 50 to 60 million tests a year that would be split between SARS-Cov-2 antigen testing and serology testing.

    The company is also ramping up production of the Sofia analyzer units, with the goal of ramping from 1,000 a month to around 7,000 a month by September, Bryant said.

    On BD's Q2 earnings call on Thursday, President and CEO Tom Polen said the company was in the process of developing a SARS-Cov-2 antigen test on its Veritor immunoassay system. He said the company was currently evaluating its performance in patient samples and that pending the outcome of that evaluation it will submit the test for EUA, potentially in the next several weeks.

    He said BD had invested in manufacturing capacity to scale the production of the test over the balance of the year and that it aimed to produce on the order of millions of tests per week.

    Roche reiterated this week in a discussion with Cowen analysts its plans to develop a SARS-CoV-2 antigen test but did not provide a timeline for when it hoped to have it available.

    The ultimate impact of these tests will, of course, hinge on their performance.

    On an FDA town hall this week about SARS-CoV-2 for test developers and clinical labs, Timothy Stenzel, director of the Food and Drug Administration's Office of In Vitro Diagnostics and Radiological Health, noted that molecular testing had not been able to keep up with demand and that the agency was "very encouraged that there are a number of developers that are developing rapid antigen tests."

    "The advantage of the rapid antigen tests is that they can be produced in quantities of millions and that they can be point of care and obviously yield a rapid result," he said, adding that FDA is "working very hard with some rapid antigen test developers in order to try to make those available in the not too distant future."

    Stenzel added that while, traditionally, rapid antigen tests have not been as sensitive as molecular tests, "there may still be value if users understand the performance of these tests and the proper use of these tests and the proper interpretation and use of results."

    For instance, he said, rapid antigen tests with high specificity could allow for quick action on positive results while negative results could potentially be reflexed to molecular testing.

    Ledeboer said that IVD firms have had success developing effective infectious disease antigen tests using both point-of-care analyzer technology and lateral flow-based home testing formats, though, like Stenzel, he noted that sensitivity can pose a challenge given the lack of the sort of antigen amplification afforded by PCR-based techniques.

    "When you start thinking about [antigen testing for] infectious diseases, you really run into sensitivity challenges in many cases," he said. "Are there ways around it? Sure. But the technological hurdles become greater."

    Emerging research on the progression of COVID-19 could bode well for antigen test developers, Ledeboer said, citing the success researchers have had using saliva samples and nasal swabs (as opposed to more invasive nasopharyngeal swabs) for PCR testing.

    "We're beginning to understand more and more that some of these less invasive specimen types do have high levels of virus, particularly in the early stages of the disease," he said, noting that some research indicates that people are shedding virus at the highest rate in the earlier stages of the disease when the virus is concentrated in the upper respiratory system.

    "It's likely that as people move a little bit later in the disease that the virus moves into the lower respiratory tract, especially as you start to see things like shortness of breath, and then you may lose a little bit of [test sensitivity] later in the disease," he said.

    This story first appeared in our sister publication 360Dx, which provides in-depth coverage of in vitro diagnostics and the clinical lab market.

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    Teladoc reports $383.3M in fourth-quarter revenue, up 145%
    Teladoc reports $383.3M in fourth-quarter revenue, up 145%
    Oscar Health's $1B IPO sets the stage for more health tech exits in 2021
    Oscar Health's $1B IPO sets the stage for more health tech exits in 2021
    Sponsored Content
    Get Free Newsletters

    Sign up for free enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today

    The weekly magazine, websites, research and databases provide a powerful and all-encompassing industry presence. We help you make informed business decisions and lead your organizations to success.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS
    • Instagram

    Stay Connected

    Join the conversation with Modern Healthcare through our social media pages

    MDHC_Logotype_white
    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Advertise with Us
    • Ad Choices Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2021. Crain Communications, Inc. All Rights Reserved.
    • News
      • This Week's News
      • COVID-19
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition
    • Insights
      • ACA 10 Years After
      • Best Practices
      • Special Reports
      • Innovations
    • Transformation
      • Patients
      • Operations
      • Care Delivery
      • Payment
    • Data/Lists
      • Rankings/Lists
      • Interactive Databases
      • Data Points
    • Op-Ed
      • Bold Moves
      • Breaking Bias
      • Commentaries
      • Letters
      • Vital Signs Blog
      • From the Editor
    • Awards
      • Award Programs
        • 100 Most Influential People
        • 50 Most Influential Clinical Executives
        • Best Places to Work in Healthcare
        • Health Care Hall of Fame
        • Healthcare Marketing Impact Awards
        • Top 25 Emerging Leaders
        • Top 25 Innovators
        • Minorities in Healthcare
          • - Luminaries
          • - Top 25 Minority Leaders
          • - Minorities to Watch
        • Women in Healthcare
          • - Luminaries
          • - Top 25 Women Leaders
          • - Women to Watch
      • Nominate
      • Previous Award Programs
        • Excellence in Nursing Awards
        • Design Awards
        • Top 25 COOs in Healthcare
      • Other Award Programs
        • 100 Top Hospitals
        • ACHE Awards
    • Events
      • Conferences
        • Women Leaders in Healthcare Conference
        • Social Determinants of Health Symposium
        • Healthcare Transformation Summit
        • Leadership Symposium
        • Virtual Briefings
          • - Hospital of the Future
          • - Mental Health
          • - Patient Safety & Quality
          • - Strategic Marketing
          • - Virtual Health
          • - Workplace of the Future
      • Galas
        • Best Places to Work Awards Gala
        • Health Care Hall of Fame Gala
        • Top 25 Minority Leaders Gala
        • Top 25 Women Leaders Gala
      • Webinars
      • COVID-19 Event Tracker
    • Listen
      • Podcast - Next Up
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Video Series - The Check Up
      • Sponsored Video Series - One on One
    • MORE +
      • Advertise
      • Media Kit
      • Newsletters
      • Jobs
      • People on the Move
      • Reprints & Licensing